Literature DB >> 27888989

Burden and risk factors of ambulatory or hospitalized CAP: A population based cohort study.

Martin Kolditz1, Falko Tesch2, Luise Mocke2, Gert Höffken3, Santiago Ewig4, Jochen Schmitt2.   

Abstract

BACKGROUND: Data on incidence, risk factors and outcome of community-acquired pneumonia (CAP) including outpatients is sparse.
METHODS: We conducted a cohort study on 1.837.080 adults insured by a German statutory health insurance in 2010-2011. CAP was identified via ICD-10-GM codes, ambulatory cases were validated by antibiotic prescription within 7 days. Primary outcomes were incidence, hospitalisation and 30-day all-cause mortality. Evaluated risk factors included age, sex and comorbidities. Evaluation was done by multivariate regression analysis adjusting for these factors and health care utilization.
RESULTS: CAP incidence was 9.7 per 1000 person years, hospitalisation rate 46.5%, and 30-day mortality 12.9%. 30-day mortality of ambulatory cases was 5% (with 27% subsequently hospitalized for another diagnosis before death). 30-day mortality of hospitalized patients was 21.9%, but in-hospital mortality 17.2%. Risk factors for CAP included age, male sex and all evaluated comorbidities with highest risk for neurologic (OR 2.4), lung (OR 2.3) or immunosuppressive (OR 2.1) disease. Mortality risk was highest for neurologic (OR 2.3) and malignant (OR 2.0) disease.
CONCLUSIONS: CAP constitutes a major burden in terms of incidence, morbidity and all-cause mortality in hospitalized and ambulatory patients. Interventions to raise awareness for disease impact also in ambulatory patients with risk factors are warranted. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Community-acquired pneumonia; Hospitalisation; Incidence; Mortality; Risk factor

Mesh:

Year:  2016        PMID: 27888989     DOI: 10.1016/j.rmed.2016.10.015

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  18 in total

1.  Community-Acquired Pneumonia in Adults.

Authors:  Martin Kolditz; Santiago Ewig
Journal:  Dtsch Arztebl Int       Date:  2017-12-08       Impact factor: 5.594

Review 2.  Burden of Community-Acquired Pneumonia and Unmet Clinical Needs.

Authors:  João Ferreira-Coimbra; Cristina Sarda; Jordi Rello
Journal:  Adv Ther       Date:  2020-02-18       Impact factor: 3.845

Review 3.  [Community-acquired pneumonia].

Authors:  M Hecker; N Sommer; K Tello; A Hecker; W Seeger; K Mayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-04-10       Impact factor: 0.840

4.  The Role of Pneumococcal Pneumonia among Community-Acquired Pneumonia in Adult Turkish Population: TurkCAP Study.

Authors:  Esin Şenol; Aykut Çilli; Hakan Günen; Alper Şener; Rıdvan Dumlu; Ayşe Ödemiş; Ayşe Füsun Topçu; Yeşim Yıldız; Rahmet Güner; Ayhan Özhasenekler; Birsen Mutlu; Nurdan Köktürk; Nurgül Sevimli; Nurcan Baykam; Derya Yapar; Selami Ekin; Mehmet Polatlı; Şebnem Eren Gök; Oğuz Kılınç; Abdullah Sayıner; Ömer Karaşahin; Çağlar Çuhadaroğlu; Ayşe Sesin Kocagöz; Turhan Togan; Hüseyin Arpağ; Hakan Katı; İftihar Köksal; Firdevs Aksoy; Canan Hasanoğlu
Journal:  Turk Thorac J       Date:  2021-07

5.  Utility of quick sepsis-related organ failure assessment (qSOFA) to predict outcome in patients with pneumonia.

Authors:  Martin Müller; Viviane Guignard; Joerg C Schefold; Alexander B Leichtle; Aristomenis K Exadaktylos; Carmen A Pfortmueller
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

6.  Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.

Authors:  Ulrike Kuchenbecker; Daniela Chase; Anika Reichert; Julia Schiffner-Rohe; Mark Atwood
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

7.  Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST).

Authors:  Zhijie Zhang; Meng Chen; Ying Yu; Sisi Pan; Yong Liu
Journal:  Infect Drug Resist       Date:  2019-05-10       Impact factor: 4.003

8.  Population-based incidence and mortality of community-acquired pneumonia in Germany.

Authors:  Christian Theilacker; Ralf Sprenger; Friedhelm Leverkus; Jochen Walker; Dennis Häckl; Christof von Eiff; Julia Schiffner-Rohe
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

Review 9.  Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.

Authors:  Ronald Anderson; Jan G Nel; Charles Feldman
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

10.  Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.

Authors:  Sarah Berger; Cengiz Goekeri; Shishir K Gupta; Julio Vera; Kristina Dietert; Ulrike Behrendt; Jasmin Lienau; Sandra-Maria Wienhold; Achim D Gruber; Norbert Suttorp; Martin Witzenrath; Geraldine Nouailles
Journal:  Crit Care       Date:  2018-11-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.